Can these drugs help cancer patients ditch steroids?
NCT ID NCT04375228
First seen Feb 06, 2026 · Last updated May 23, 2026 · Updated 13 times
Summary
This study tests whether rituximab or tocilizumab can help people with advanced cancer stop taking steroids for side effects caused by immunotherapy. The trial enrolled 8 participants who had steroid-dependent immune-related side effects. The goal is to see if these drugs can control the side effects so patients can safely stop steroids within 4 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
-
Johns Hopkins
Baltimore, Maryland, 21224, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10022, United States
Conditions
Explore the condition pages connected to this study.